DK1603580T3 - Præparat til indgivelse af jern til behandling af Restless Legs Syndrom - Google Patents
Præparat til indgivelse af jern til behandling af Restless Legs SyndromInfo
- Publication number
- DK1603580T3 DK1603580T3 DK03816391T DK03816391T DK1603580T3 DK 1603580 T3 DK1603580 T3 DK 1603580T3 DK 03816391 T DK03816391 T DK 03816391T DK 03816391 T DK03816391 T DK 03816391T DK 1603580 T3 DK1603580 T3 DK 1603580T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- treatment
- restless legs
- legs syndrome
- iron administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/389,228 US6960571B2 (en) | 2003-03-14 | 2003-03-14 | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
PCT/US2003/015087 WO2004082693A1 (en) | 2003-03-14 | 2003-05-13 | Composition for administration of iron for the treatment of restless legs syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1603580T3 true DK1603580T3 (da) | 2008-10-06 |
Family
ID=32962229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03816391T DK1603580T3 (da) | 2003-03-14 | 2003-05-13 | Præparat til indgivelse af jern til behandling af Restless Legs Syndrom |
Country Status (26)
Country | Link |
---|---|
US (1) | US6960571B2 (el) |
EP (1) | EP1603580B1 (el) |
JP (2) | JP2006520322A (el) |
KR (1) | KR100978377B1 (el) |
CN (1) | CN1771044B (el) |
AT (1) | ATE400280T1 (el) |
AU (1) | AU2003249635C1 (el) |
BR (1) | BR0318185A (el) |
CA (1) | CA2518971C (el) |
CY (1) | CY1110407T1 (el) |
DE (1) | DE60322121D1 (el) |
DK (1) | DK1603580T3 (el) |
ES (1) | ES2309403T3 (el) |
HK (1) | HK1089666A1 (el) |
HR (1) | HRP20050796A2 (el) |
IL (1) | IL170386A (el) |
MX (1) | MXPA05009786A (el) |
NO (1) | NO20054728L (el) |
PL (1) | PL206810B1 (el) |
PT (1) | PT1603580E (el) |
RS (1) | RS51823B (el) |
RU (1) | RU2319490C2 (el) |
SI (1) | SI1603580T1 (el) |
UA (1) | UA83483C2 (el) |
WO (1) | WO2004082693A1 (el) |
ZA (1) | ZA200508308B (el) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10249552A1 (de) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel |
US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
EP1655040A1 (en) * | 2004-10-08 | 2006-05-10 | Bracco Imaging, S.P.A. | Contrast agent formulations for the visualization of the lymphatic system |
EP1790356A1 (de) * | 2005-11-24 | 2007-05-30 | Vifor (International) Ag | Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en) |
EA200801540A1 (ru) * | 2005-12-20 | 2008-12-30 | Сириусайенс Аб | Способ и композиция для лечения и диагностики синдрома усталых ног |
ES2634142T3 (es) * | 2005-12-23 | 2017-09-26 | Ajay Gupta | Composición de nutrición parenteral que contiene hierro |
AU2013206429B2 (en) * | 2006-01-06 | 2016-04-28 | Vifor (International) Ag | Methods and compositions for administration of iron |
AU2016205002C1 (en) * | 2006-01-06 | 2020-09-24 | Vifor (International) Ag | Methods and compositions for administration of iron |
CA2635894C (en) * | 2006-01-06 | 2017-09-12 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron |
US20080132465A1 (en) * | 2006-12-05 | 2008-06-05 | Vincent Windisch | Apparatus and method for isolating iron components from serum |
EP1941869A1 (en) * | 2007-01-04 | 2008-07-09 | Vifor (International) Ag | Multicompartment bag for storage of iron preparations |
EP2265113B1 (en) * | 2008-03-28 | 2014-07-16 | Chyna Llc | Use of ferritin to treat iron deficiency disorders |
WO2009143439A1 (en) * | 2008-05-23 | 2009-11-26 | Hospira, Inc. | Packaged iron sucrose products |
BRPI0921431A2 (pt) * | 2008-11-06 | 2017-06-06 | Biotie Therapies Ag | método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono |
CA2756580A1 (en) | 2009-03-25 | 2010-09-30 | Hans Andreasen | A stable iron oligosaccharide compound |
US8058076B2 (en) * | 2009-03-31 | 2011-11-15 | Astron Research Limited | In-vitro method for testing bioequivalence of iron-sucrose formulation |
CN102440999A (zh) * | 2010-10-15 | 2012-05-09 | 天津瑞普生物技术股份有限公司 | 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物 |
WO2012104204A1 (en) | 2011-01-31 | 2012-08-09 | Vifor (International) Ag | Iron-carbohydrate complex compounds for the intravenous therapy of malaria |
DK2968503T3 (en) | 2013-03-15 | 2018-12-03 | Intrinsic Lifesciences Llc | ANTI-HEPCIDIN ANTIBODIES AND APPLICATIONS THEREOF |
JP2014132029A (ja) * | 2014-04-03 | 2014-07-17 | Chyna Llc | 鉄欠乏性障害を治療するためのフェリチンの使用 |
NZ730186A (en) | 2014-09-22 | 2020-04-24 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
WO2016069950A2 (en) * | 2014-10-29 | 2016-05-06 | University Of Utah Research Foundation | Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1) |
EP2913054A1 (en) | 2015-03-19 | 2015-09-02 | Pharmacosmos Holding A/s | Iron carbohydrate complex for treatment of restless leg syndrome (rls) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4827945A (en) | 1986-07-03 | 1989-05-09 | Advanced Magnetics, Incorporated | Biologically degradable superparamagnetic materials for use in clinical applications |
US5248492A (en) | 1986-07-03 | 1993-09-28 | Advanced Magnetics, Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
US5700832A (en) * | 1994-10-19 | 1997-12-23 | Daewon Pharm. Co., Ltd. | Antianemic agent containing iron and difructose |
SE9803760D0 (sv) | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
US6611707B1 (en) * | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
AU2001251306A1 (en) | 2000-04-04 | 2001-10-15 | Siegel, Jerome M. | Treatment of sleep disorders with hypocretin-1 |
-
2003
- 2003-03-14 US US10/389,228 patent/US6960571B2/en not_active Expired - Lifetime
- 2003-05-13 BR BRPI0318185-5A patent/BR0318185A/pt not_active Application Discontinuation
- 2003-05-13 CA CA002518971A patent/CA2518971C/en not_active Expired - Lifetime
- 2003-05-13 EP EP03816391A patent/EP1603580B1/en not_active Expired - Lifetime
- 2003-05-13 KR KR1020057017249A patent/KR100978377B1/ko not_active IP Right Cessation
- 2003-05-13 WO PCT/US2003/015087 patent/WO2004082693A1/en active Application Filing
- 2003-05-13 AU AU2003249635A patent/AU2003249635C1/en not_active Ceased
- 2003-05-13 AT AT03816391T patent/ATE400280T1/de active
- 2003-05-13 JP JP2004569663A patent/JP2006520322A/ja active Pending
- 2003-05-13 MX MXPA05009786A patent/MXPA05009786A/es active IP Right Grant
- 2003-05-13 ES ES03816391T patent/ES2309403T3/es not_active Expired - Lifetime
- 2003-05-13 CN CN038260972A patent/CN1771044B/zh not_active Expired - Fee Related
- 2003-05-13 DE DE60322121T patent/DE60322121D1/de not_active Expired - Lifetime
- 2003-05-13 DK DK03816391T patent/DK1603580T3/da active
- 2003-05-13 PT PT03816391T patent/PT1603580E/pt unknown
- 2003-05-13 UA UAA200508760A patent/UA83483C2/uk unknown
- 2003-05-13 RU RU2005131832/14A patent/RU2319490C2/ru not_active IP Right Cessation
- 2003-05-13 RS YU20050695A patent/RS51823B/sr unknown
- 2003-05-13 SI SI200331383T patent/SI1603580T1/sl unknown
- 2003-05-13 PL PL378875A patent/PL206810B1/pl not_active IP Right Cessation
-
2005
- 2005-08-18 IL IL170386A patent/IL170386A/en not_active IP Right Cessation
- 2005-09-12 HR HR20050796A patent/HRP20050796A2/hr not_active Application Discontinuation
- 2005-10-13 ZA ZA200508308A patent/ZA200508308B/en unknown
- 2005-10-13 NO NO20054728A patent/NO20054728L/no not_active Application Discontinuation
-
2006
- 2006-09-11 HK HK06110065.3A patent/HK1089666A1/xx not_active IP Right Cessation
-
2008
- 2008-10-08 CY CY20081101119T patent/CY1110407T1/el unknown
-
2010
- 2010-05-26 JP JP2010120637A patent/JP2010180252A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1603580T3 (da) | Præparat til indgivelse af jern til behandling af Restless Legs Syndrom | |
HK1085140A1 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
DK1505990T3 (da) | Fremgangsmåder til behandling af hepatitis | |
SG146643A1 (en) | Treating or preventing restless legs syndrome using prodrugs of gaba analogs | |
DK1263729T3 (da) | Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme | |
DE602005024571D1 (de) | Opioide zur behandlung von ruhelosigkeit in den unteren gliedmassen | |
DK1501499T3 (da) | Transepikutan indgivelsesform til behandling af restless legs-syndromet | |
SG146648A1 (en) | Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation | |
MX2007004955A (es) | Metodo de tratar cancer con formulaciones de compeusto de platino a base de lipido administradas intraperitonealmente. | |
EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
WO2007055804A3 (en) | Methods and compositions for administration of iron for the treatment of restless leg syndrome | |
EA200501821A1 (ru) | Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат | |
DK1030667T3 (da) | Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö | |
EA200801731A1 (ru) | Составы и способы лечения тробмоцитемии | |
MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
NO20062570L (no) | Imidazo[1,2-A] pyridin derivater for behandling av stille gastroosofagial refluks | |
FR2860234B1 (fr) | Nouveaux derives 666 du thioxylose | |
RU2013148539A (ru) | Алиспоривир для лечения инфекции вируса гепатита с | |
EA200701010A1 (ru) | Препарат гепирона с высокой дозировкой и длительным высвобождением | |
ATE454144T1 (de) | Behandlung von malignen neoplasien | |
ATE425755T1 (de) | 4-aminophenyl-morpholinon-derivate zur behandlung von hepatitis c | |
DK1677808T3 (da) | Kombinationspræparat til behanding af sepsis | |
RU2004104555A (ru) | Способ лечения диабетической ретинопатии, осложненной гемофтальмом | |
UA50298A (uk) | Спосіб лікування синдрому діабетичної стопи | |
DK1311286T3 (da) | Behandling af hepatitis C med thymosin og pegyleret interferon |